ArticleSingapore medical journal2020
Corticosteroid phobia: a questionnaire study using TOPICOP score.
Article in Singapore medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.
- Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions.American journal of clinical dermatology · 2021Pooled it
- A comparison between mometasone furoate nasal spray and intranasal glycyrrhetic acid in patients with allergic rhinitis: a preliminary study in clinical practice.Acta bio-medica : Atenei Parmensis · 2020Trial
- Topical Corticosteroid-Related Concerns and Phobic Behaviors in Saudi Arabia: A Cross-Sectional Investigation.Healthcare (Basel, Switzerland) · 2026Article
- Digital psychotherapeutic interventions to reduce dermatological symptom burden: Development and testing of MindMySkin.JAAD international · 2026Article
- Corticosteroid Phobia in Patients with Atopic Dermatitis: A Narrative Review.Clinical, cosmetic and investigational dermatology · 2026Review
- The Paradox of Education and the Failure of Communication: A Cross-Sectional Study of Topical Corticosteroid Phobia and Its Impact on Treatment Adherence Among Urban Primary Care Patients in Shenzhen, China.Patient preference and adherence · 2026Article
- Personality Traits and Treatment Adherence Among Parents of Children with Atopic Dermatitis.Medicina (Kaunas, Lithuania) · 2025Article
- Topical corticosteroid phobia among caregivers: a study in atopic and nonatopic dermatitis children by using the TOPICOP score.Skin health and disease · 2025Article
- Observational Study of Corticosteroid Phobia Using the TOPICOP Score among Adults and Caregivers of Children with Atopic Dermatitis in Japan.Dermatology and therapy · 2025Article
- Validity and reliability of the Turkish version of the topical corticosteroid phobia (TOPICOP) scale.Turkish journal of medical sciences · 2025Article
- Corticosteroid Phobia: A Key Barrier to Treatment in Young Women with Idiopathic Granulomatous Mastitis.International journal of women's health · 2025Article
- Predictors of Topical Corticosteroid Adherence Among Caregivers of Children with Atopic Eczema.Patient preference and adherence · 2025Article
- Investigating Topical Steroid Withdrawal Videos on TikTok: Cross-Sectional Analysis of the Top 100 Videos.JMIR formative research · 2024Observational
- Topical Corticophobia Among Healthcare Professionals in Saudi Arabia: A Cross-Sectional Study.Dermatology practical & conceptual · 2024Article
- Linguistic Validation and Reliability of the Croatian Version of the TOPICOP Questionnaire.Medicina (Kaunas, Lithuania) · 2024Observational
- Paediatric alopecia areata cases in a tertiary institution in Singapore: a retrospective review.Singapore medical journal · 2024Article
- Article
- An evaluation of pharmacists' general attitudes, knowledge, and phobias regarding medications that include corticosteroids: a cross-sectional study.Journal of pharmaceutical health care and sciences · 2024Article
- Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores.Journal of clinical medicine · 2023Article
- Evaluation of knowledge, experiences, and fear toward prescribing and dispensing corticosteroids among Egyptian healthcare professionals: A cross-sectional study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTopical corticosteroids (TCS) are commonly used in dermatology for their anti-inflammatory action. The recent development of the TOPICOP© (Topical Corticosteroid Phobia) scale to assess steroid phobia has made the quantification and comparison of steroid phobia easier. The objective of this study was to assess the degree of steroid phobia at our institute and identify sources from which patients obtain information regarding TCS.
methodsA cross-sectional survey was performed of dermatology patients regardless of steroid use. TOPICOP scale was used for the survey. Sources from which patients obtained information were identified and their level of trust in these sources assessed.
results186 surveys were analysed. The median domain TOPICOP subscores were 38.9% (interquartile range [IQR] 27.8%-50.0%, standard deviation [SD] 24.4%) for knowledge and beliefs, 44.4% (IQR 33.3%-66.7%, SD 24.4%) for fears and 55.6% (IQR 33.3%-66.7%, SD 27.2%) for behaviour. The median global TOPICOP score was 44.4% (IQR 33.3%-55.6%, SD 17.6%). Female gender was associated with higher behaviour, fear and global TOPICOP scores. There was no difference in the scores based on disease condition, steroid use, age or education. Dermatologists were the most common source of information on topical steroids and trust was highest in dermatologists.
conclusionThe prevalence of steroid phobia in our dermatology outpatient setting was moderately high, with gender differences. Dermatologists were the most common source of information on TCS, and it was heartening to note that trust was also highest in dermatologists. Strategies to target steroid phobia should take into account these factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.